Digitalis Therapy Is Associated With an Increased Risk of ICD Shock Delivery and Device Revision
Annals of Noninvasive Electrocardiology · 2025
DOI: 10.1111/anec.70080 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Noninvasive Electrocardiology, 2025. Verfasst von Gerrit Frommeyer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Cardiology II - Electrophysiology, University of Münster, Münster, Germany. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Digitalis Glycosides. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Digitalis glycosides are employed for rate control of atrial fibrillation and treatment of heart failure. Previous studies suggested potential harmful effects of digitalis therapy. The aim of the present study was to assess the prevalence and potential impact of digitalis therapy on outcomes in patients with systolic failure who were implanted with an ICD‐ or CRT‐ICD system. Methods and Results The German Device Registry is a nationwide, prospective registry with a 1‐year follow‐up investigating 4384 patients receiving either ICD or CRT systems in 52 German centers. The present analysis focused on the presence of digitalis therapy in 3826 patients undergoing device implantation. Patients receiving digitalis therapy ( n = 800) presented a more severely impaired left ventricular function, higher NYHA class, and an increased incidence of left bundle branch block. Consequently, the implantation of CRT systems was more common in this group. One‐year mortality did not significantly differ between both groups (9.1% vs. 7.4%, p = 0.14). Similar results were obtained for the combined endpoint, including death, myocardial infarction, and stroke. ICD shock delivery (19.7% vs. 15.0%, p = 0.006) and device revision (11.4% vs. 7.5%, p < 0.004) were more common in digitalis‐treated patients.
Conclusion
In this study in patients undergoing ICD or CRT implantation, an association of digitalis therapy with an increased risk of device revision was observed. Of note, mortality or severe cardiovascular events did not differ between both groups. Furthermore, an increased risk of ICD shock delivery was observed in digitalis‐treated patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic for Cardiology II - Electrophysiology, University of Münster, Münster, Germany.
- Department of Cardiology, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany.
- Department of Cardiology, Klinikum Bielefeld, Bielefeld, Germany.
- Department of Cardiology, Vivantes Klinikum Am Urban and Neukölln, Berlin, Germany.
- Rostock University, Rostock, Germany.
- Medical School REGIOMED, University of Split School of Medicine, Split, Croatia.
ORCID-Profile: Gerrit Frommeyer
Zitieren
APA
Frommeyer, G., Lange, P. S., Kleemann, T., Stellbrink, C., Ince, H., Brachmann, J., Lewalter, T., Hochadel, M., Senges, J., & Eckardt, L. (2025). Digitalis Therapy Is Associated With an Increased Risk of ICD Shock Delivery and Device Revision. Annals of Noninvasive Electrocardiology. https://doi.org/10.1111/anec.70080
Vancouver
Frommeyer G, Lange PS, Kleemann T, Stellbrink C, Ince H, Brachmann J, et al. Digitalis Therapy Is Associated With an Increased Risk of ICD Shock Delivery and Device Revision. Annals of Noninvasive Electrocardiology. 2025. doi:10.1111/anec.70080
BibTeX
@article{Frommeyer2025,
author = {Frommeyer, Gerrit and Lange, Philipp S and Kleemann, Thomas and Stellbrink, Christoph and Ince, Hüseyin and Brachmann, Johannes and Lewalter, Thorsten and Hochadel, Matthias and Senges, Jochen and Eckardt, Lars},
title = {Digitalis Therapy Is Associated With an Increased Risk of ICD Shock Delivery and Device Revision},
journal = {Annals of Noninvasive Electrocardiology},
year = {2025},
doi = {10.1111/anec.70080}
}
EUVIMED